Skip to content

Application of Mobile APP-based Exercise Intervention Program in Adults with Prediabetes: A Randomized Clinical Trial

Application of Mobile APP-based Exercise Intervention Program in Adults with Prediabetes: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063588
Enrollment
Unknown
Registered
2022-09-12
Start date
2022-09-12
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes

Interventions

Health Education Group:Health Education

Sponsors

Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) 30 to 60 years old, 18.5kg / m2 = BMI = 30kg / m2; (2) It conforms to the definition of prediabetes patients in the expert consensus on prediabetes intervention in Chinese adults (2020 Edition): that is, those who meet any of the following two points: ? impaired fasting glucose (IFG): 6.1mmol/l = fasting glucose < 7mmol/l and 2h OGTT <7.8mmol/l; ? Impaired glucose tolerance (IGT): fasting blood glucose < 7mmol/l and 7.8mmol/l = 2h OGTT < 11.1 mmol / L; (3) Muscle strength of limbs = level 4 (able to resist medium load and have complete range of motion); (4) Irregular exercise habits before participating in this study (regular exercise time per week has accumulated more than 1h in the past three months); (5) Have and be able to operate smart phones skillfully; (6) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) After pre exercise screening, patients with high risk of exercise or exercise contraindications are not suitable for exercise intervention (2) Patients who have been diagnosed with diabetes or have used hypoglycemic drugs such as metformin to prevent diabetes (3) Patients with malignant tumors; (4) Combined with mental, neurological, skeletal and muscular diseases that cannot complete exercise; (5) Combined with cardiovascular and cerebrovascular diseases: arrhythmia (frequent ventricular premature beats, ventricular tachycardia, degree II, type II and degree III atrioventricular block, uncontrolled atrial tachycardia, mural thrombosis, ventricular aneurysm, dysfunction or rupture of cardiac papillary muscle, severe sinus bradycardia and sinus arrest, etc.), heart failure, moderate to severe stenotic heart valve disease, hypertrophic cardiomyopathy or other forms of outflow tract stenosis Acute myocarditis, pericarditis, active endocarditis, suspected or known aneurysm rupture, acute pulmonary embolism or pulmonary infarction, history of cardiac arrest, etc. Secondary hypertension, or reach the diagnostic criteria of primary hypertension but the condition is not controlled (resting blood pressure >160/100 mmHg); (6) Complicated with symptomatic or diagnosed lung and kidney diseases; (7) Complicated with acute non cardiogenic diseases (such as infection, fever, renal failure, hyperthyroidism, etc.); (8) Unexplained dizziness, chest pain, shortness of breath, palpitations, etc; (9) Pregnant women; (10) Patients who have taken diet pills in recent 3 months ß Receptor agonists (excluding inhalants), oral corticosteroids, antidepressants or antipsychotics.

Design outcomes

Primary

MeasureTime frame
HbA1c;fasting blood glucose;2h OGTT;Fasting serum lisulin;HOMA-IR;HOMA-ß;HOMA-IS;ISI;Disposition index;

Secondary

MeasureTime frame
Body Mass Index;body weight;Serum total cholesterol;Triglyceride;High density lipoprotein cholesterol;Low density lipoprotein cholesterol;alanine transaminase;Aspartate transaminase;?-glutamyl transpeptadase;uric acid;Gut microbiota;Body fat percentage;maximal oxygen consumption;Amino acid;

Countries

China

Contacts

Public ContactShuai Ping

Department of Health Management & Physical Examination, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China,Chengdu, China

8369898@qq.com18030857580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026